PL2491919T3 - Roztwór farmaceutyczny taksanów zawierający regulator ph i sposób jego wytwarzania - Google Patents

Roztwór farmaceutyczny taksanów zawierający regulator ph i sposób jego wytwarzania

Info

Publication number
PL2491919T3
PL2491919T3 PL10824478T PL10824478T PL2491919T3 PL 2491919 T3 PL2491919 T3 PL 2491919T3 PL 10824478 T PL10824478 T PL 10824478T PL 10824478 T PL10824478 T PL 10824478T PL 2491919 T3 PL2491919 T3 PL 2491919T3
Authority
PL
Poland
Prior art keywords
taxanes
regulator
preparation
pharmaceutical solution
pharmaceutical
Prior art date
Application number
PL10824478T
Other languages
English (en)
Other versions
PL2491919T5 (pl
Inventor
Jianming Chen
Baoan Gao
Li Deng
Qiuxia Yang
Jing Sun
Wei Liu
Peng Gu
Yingying Zhang
Jialiang Zhang
Original Assignee
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43899845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2491919(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. filed Critical Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
Publication of PL2491919T3 publication Critical patent/PL2491919T3/pl
Publication of PL2491919T5 publication Critical patent/PL2491919T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL10824478T 2009-10-23 2010-10-22 Roztwór farmaceutyczny taksanów zawierający regulator ph i sposób jego wytwarzania PL2491919T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2009100709318A CN102038635A (zh) 2009-10-23 2009-10-23 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
EP10824478.1A EP2491919B2 (en) 2009-10-23 2010-10-22 Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof
PCT/CN2010/077996 WO2011047637A1 (zh) 2009-10-23 2010-10-22 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法

Publications (2)

Publication Number Publication Date
PL2491919T3 true PL2491919T3 (pl) 2017-08-31
PL2491919T5 PL2491919T5 (pl) 2019-12-31

Family

ID=43899845

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10824478T PL2491919T5 (pl) 2009-10-23 2010-10-22 Roztwór farmaceutyczny taksanów zawierający regulator ph i sposób jego wytwarzania

Country Status (10)

Country Link
US (1) US9241922B2 (pl)
EP (1) EP2491919B2 (pl)
JP (1) JP5847722B2 (pl)
KR (1) KR101722398B1 (pl)
CN (2) CN102038635A (pl)
AR (1) AR078736A1 (pl)
AU (1) AU2010310258B2 (pl)
CA (1) CA2765748C (pl)
PL (1) PL2491919T5 (pl)
WO (1) WO2011047637A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2205215A2 (en) * 2007-10-01 2010-07-14 Intas Pharmaceuticals Limited Docetaxel injectable composition, being absolutely free of ethanol
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JP2013194009A (ja) * 2012-03-21 2013-09-30 Nipro Corp ドセタキセル製剤
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
JP6076744B2 (ja) * 2013-01-04 2017-02-08 ナガセ医薬品株式会社 ドセタキセル含有医薬組成物
JP6292267B2 (ja) * 2016-09-13 2018-03-14 ニプロ株式会社 ドセタキセル製剤
JP2018115178A (ja) * 2018-03-15 2018-07-26 ニプロ株式会社 ドセタキセル製剤
CN111153535B (zh) * 2020-01-19 2022-03-25 武汉市新华印刷有限责任公司 一种显影机冲版废水处理系统

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
EP1465618A2 (en) 2001-12-20 2004-10-13 Bristol-Myers Squibb Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
US20040122081A1 (en) 2002-11-08 2004-06-24 Gogate Uday Shankar Pharmaceutical compositions and methods of using taxane derivatives
CN1535679A (zh) 2003-04-04 2004-10-13 齐鲁制药厂 含有紫杉醇类物质的药物组合物及其制备方法
WO2005095462A1 (en) * 2004-03-31 2005-10-13 Showa Denko K.K. Moisture retention polymer compound
WO2006033476A1 (en) * 2004-09-24 2006-03-30 Showa Denko K.K. Hydroxycitric acid derivatives and skin external preparations containing the same
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
JP4929158B2 (ja) * 2005-03-14 2012-05-09 株式会社大塚製薬工場 難水溶性薬物を含有する医薬組成物
EP2138164A1 (en) * 2005-06-17 2009-12-30 Hospira Australia Pty Ltd Liquid pharmaceutical formulations of docetaxel
JP2007032374A (ja) 2005-07-25 2007-02-08 Usui Kokusai Sangyo Kaisha Ltd フューエルデリバリパイプ
CN101023940A (zh) * 2006-02-20 2007-08-29 郝守祝 一种紫杉烷类化合物的药用组合物、制备方法及用途
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
CN101244053B (zh) 2007-02-16 2010-12-08 石药集团中奇制药技术（石家庄）有限公司 以多西他赛为主组分的新的分散体系
JP2010530872A (ja) 2007-06-22 2010-09-16 サイドース・エルエルシー Ｔｗｅｅｎ８０を含まないドセタキセル可溶化製剤
EP2205215A2 (en) 2007-10-01 2010-07-14 Intas Pharmaceuticals Limited Docetaxel injectable composition, being absolutely free of ethanol
CN101288642B (zh) * 2007-11-07 2011-04-27 天津天士力集团有限公司 一种紫杉烷类药物静脉给药制剂及其制备方法
AP2895A (en) 2007-12-24 2014-05-31 Sun Pharma Advanced Res Co Ltd Nanodispersion

Also Published As

Publication number Publication date
EP2491919B2 (en) 2019-06-26
HK1164708A1 (en) 2012-09-28
WO2011047637A1 (zh) 2011-04-28
KR101722398B1 (ko) 2017-05-17
JP2013508312A (ja) 2013-03-07
EP2491919B1 (en) 2016-05-11
EP2491919A4 (en) 2013-09-18
CA2765748A1 (en) 2011-04-28
JP5847722B2 (ja) 2016-01-27
EP2491919A1 (en) 2012-08-29
US9241922B2 (en) 2016-01-26
KR20120087902A (ko) 2012-08-07
PL2491919T5 (pl) 2019-12-31
AU2010310258A1 (en) 2012-01-19
AU2010310258B2 (en) 2013-09-19
CN102448441A (zh) 2012-05-09
AR078736A1 (es) 2011-11-30
CN102448441B (zh) 2014-09-17
CA2765748C (en) 2016-10-25
CN102038635A (zh) 2011-05-04
US20120157517A1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
PL2491919T5 (pl) Roztwór farmaceutyczny taksanów zawierający regulator ph i sposób jego wytwarzania
IL219351A0 (en) Drug delivery devices and method of assembly
SG10201912687WA (en) Stable Pharmaceutical Composition And Methods Of Using Same
NO2016023I1 (no) Glycerol fenylbutyrat
IL217292A0 (en) Polypeptides and method of treatment
ZA201107555B (en) Anti-17f antibodies and methods of use thereof
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
EP2435935A4 (en) METHOD OF PROVIDING A POSTCARD PATENT CARD AND SYSTEM THEREOF
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
IL197655A0 (en) Emulsions and methods of their production
ZA201109514B (en) Method of drug delivery
IL231505A0 (en) Pharmaceutical preparation and method for its production
ZA201203060B (en) Composition and method of delivery
ZA201202892B (en) Ophthalmic formulation and method of manufacture thereof
LT2741790T (lt) Medicininiai klijai ir jų gamybos būdas
GB2488494B (en) Solution, use and method of preparation thereof
PL2569168T3 (pl) Wkładka informacyjna leku i sposób jej wytwarzania
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES
PL387415A1 (pl) Kompozycja farmaceutyczna zawierająca celekoksyb oraz sposób jej wytwarzania
GB201002278D0 (en) composition and method of preparation
GB201004833D0 (en) Comsumables and method of production thereof
GB201004835D0 (en) Comsumables and method of production thereof
PL388223A1 (pl) Kompozycja farmaceutyczna zasady zyprazydonu oraz sposób jej wytwarzania
ZA201200077B (en) Polypeptides and method of treatment
PL388843A1 (pl) Sposób otrzymywania kwasu węglowego